Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2026-04-13 @ 5:54 PM
Study NCT ID:
NCT06986057
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-22
First Post:
2025-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer
Sponsor:
Shandong Tumor Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
QLMA-CC-IIT-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None